Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)

Beevers, G. et al. (2005) Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA). Diabetes Care, 28, pp. 1151-1157.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Gordon
Authors: Beevers, G., Caulfield, M., Collins, R., Dahlof, B., Kjeldsen, S., Kristinsson, A., McInnes, G., Mehlsen, J., Nieminen, M., O'Brien, E., Ostergren, J., Poulter, N., Sever, P., and Wedel, H.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Diabetes Care

University Staff: Request a correction | Enlighten Editors: Update this record